DarioHealth (NASDAQ:DRIO) Stock Price Crosses Below Fifty Day Moving Average – Time to Sell?

DarioHealth Corp. (NASDAQ:DRIO)’s share price passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $7.80 and traded as low as $7.30. DarioHealth shares last traded at $7.51, with a volume of 12,963 shares trading hands.

Analyst Upgrades and Downgrades

DRIO has been the topic of a number of analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $10.00 price target on shares of DarioHealth in a research report on Thursday, May 14th. TD Cowen reissued a “hold” rating and set a $11.00 price target on shares of DarioHealth in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $10.50.

DarioHealth Stock Down 4.5%

The firm has a market cap of $54.90 million, a price-to-earnings ratio of -0.85 and a beta of 1.09. The company has a debt-to-equity ratio of 0.50, a current ratio of 3.07 and a quick ratio of 2.62. The stock has a 50-day moving average of $7.80 and a 200-day moving average of $10.17.

Institutional Investors Weigh In On DarioHealth

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC lifted its stake in DarioHealth by 167.9% during the fourth quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after purchasing an additional 31,063 shares during the last quarter. XTX Topco Ltd lifted its stake in DarioHealth by 229.0% during the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock worth $42,000 after purchasing an additional 43,513 shares during the last quarter. Finally, Kestra Advisory Services LLC bought a new stake in DarioHealth during the fourth quarter worth $35,000. 33.39% of the stock is currently owned by institutional investors.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.